Jiangsu Huachang Chemical vs FMC: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Jiangsu Huachang Chemical Co Ltd (002274.CS)

Q3 20268 Jul – 20 Aug 2026

▲3

Huachang Chemical's profit jumps tenfold on polyol boom

Profit forecast up 1,026% on higher prices and polyol volumes On July 8, Huachang Chemical said first-half net profit would rise about 1,026% to roughly 123 million yuan. The company credited higher product selling prices and new sales from its polyol project. A profit jump that large tells investors the business is earning far more, which supports a higher share price.
This is the first hard signal of the earnings surge that drives the stock.
Half-year report confirms profit up 1,026.9%, revenue up 24.85% The August 20 report confirmed net profit of 123 million yuan, up 1,026.9%, and revenue of 4.016 billion yuan, up 24.85%. Gross margin widened to 9.01%. Fine chemicals, led by polyol, became the biggest revenue source. Confirmed results remove doubt and support the stock.
It turns the earlier forecast into audited fact, the core reason the stock is moving.
Polyol project shifts company from fertilizer to fine chemicals Polyol products brought in 2.042 billion yuan, up 79%, and fine chemicals jumped to 51.89% of revenue from 36.56%, overtaking fertilizer. This mix shift means steadier, higher-margin earnings, which investors tend to reward with a higher valuation over time.
It explains the structural change behind the profit surge, not just one quarter's numbers.
No dividend despite strong profit; chemical sector rally broad The company plans no cash dividend, bonus shares, or capital conversion for the half year, which may disappoint income-focused holders. Still, Huachang sits among many chemical firms reporting big profit gains, so sector-wide enthusiasm can lift the stock even as the payout decision weighs on sentiment.
It gives the real counterweight to the good news and the wider sector backdrop.

July 20268 Jul – 20 Aug 2026

▲3

Huachang Chemical's profit jumps tenfold on polyol boom

Profit forecast up 1,026% on higher prices and polyol volumes On July 8, Huachang Chemical said first-half net profit would rise about 1,026% to roughly 123 million yuan. The company credited higher product selling prices and new sales from its polyol project. A profit jump that large tells investors the business is earning far more, which supports a higher share price.
This is the first hard signal of the earnings surge that drives the stock.
Half-year report confirms profit up 1,026.9%, revenue up 24.85% The August 20 report confirmed net profit of 123 million yuan, up 1,026.9%, and revenue of 4.016 billion yuan, up 24.85%. Gross margin widened to 9.01%. Fine chemicals, led by polyol, became the biggest revenue source. Confirmed results remove doubt and support the stock.
It turns the earlier forecast into audited fact, the core reason the stock is moving.
Polyol project shifts company from fertilizer to fine chemicals Polyol products brought in 2.042 billion yuan, up 79%, and fine chemicals jumped to 51.89% of revenue from 36.56%, overtaking fertilizer. This mix shift means steadier, higher-margin earnings, which investors tend to reward with a higher valuation over time.
It explains the structural change behind the profit surge, not just one quarter's numbers.
No dividend despite strong profit; chemical sector rally broad The company plans no cash dividend, bonus shares, or capital conversion for the half year, which may disappoint income-focused holders. Still, Huachang sits among many chemical firms reporting big profit gains, so sector-wide enthusiasm can lift the stock even as the payout decision weighs on sentiment.
It gives the real counterweight to the good news and the wider sector backdrop.

Latest8 Jul – 20 Aug 2026

▲3

Huachang Chemical's profit jumps tenfold on polyol boom

Profit forecast up 1,026% on higher prices and polyol volumes On July 8, Huachang Chemical said first-half net profit would rise about 1,026% to roughly 123 million yuan. The company credited higher product selling prices and new sales from its polyol project. A profit jump that large tells investors the business is earning far more, which supports a higher share price.
This is the first hard signal of the earnings surge that drives the stock.
Half-year report confirms profit up 1,026.9%, revenue up 24.85% The August 20 report confirmed net profit of 123 million yuan, up 1,026.9%, and revenue of 4.016 billion yuan, up 24.85%. Gross margin widened to 9.01%. Fine chemicals, led by polyol, became the biggest revenue source. Confirmed results remove doubt and support the stock.
It turns the earlier forecast into audited fact, the core reason the stock is moving.
Polyol project shifts company from fertilizer to fine chemicals Polyol products brought in 2.042 billion yuan, up 79%, and fine chemicals jumped to 51.89% of revenue from 36.56%, overtaking fertilizer. This mix shift means steadier, higher-margin earnings, which investors tend to reward with a higher valuation over time.
It explains the structural change behind the profit surge, not just one quarter's numbers.
No dividend despite strong profit; chemical sector rally broad The company plans no cash dividend, bonus shares, or capital conversion for the half year, which may disappoint income-focused holders. Still, Huachang sits among many chemical firms reporting big profit gains, so sector-wide enthusiasm can lift the stock even as the payout decision weighs on sentiment.
It gives the real counterweight to the good news and the wider sector backdrop.

FMC Corporation (FMC)

Q3 202630 Jul – 8 Oct 2026

▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.
The guidance cut is the main new negative force on FMC's price this period.
Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.
Debt reduction is the key positive force behind the period's sharp share rally.
New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.
The Brazil filing is a new pipeline event that supports FMC's long-term growth story.
Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.
Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

September 202630 Jul – 8 Oct 2026

▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.
The guidance cut is the main new negative force on FMC's price this period.
Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.
Debt reduction is the key positive force behind the period's sharp share rally.
New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.
The Brazil filing is a new pipeline event that supports FMC's long-term growth story.
Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.
Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.

Latest30 Jul – 8 Oct 2026

▲3▼1

FMC cuts outlook on pricing, but debt cuts and new herbicide advance

Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.
The guidance cut is the main new negative force on FMC's price this period.
Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.
Debt reduction is the key positive force behind the period's sharp share rally.
New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.
The Brazil filing is a new pipeline event that supports FMC's long-term growth story.
Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.
Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.